| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM199709253371311 |
| P953 | full work available online at | http://www.nejm.org/doi/pdf/10.1056/NEJM199709253371311 |
| P698 | PubMed publication ID | 9302310 |
| P2093 | author name string | R. D. Utiger | |
| P2860 | cites work | Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. | Q44003955 |
| Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer | Q45287905 | ||
| Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma | Q58004699 | ||
| Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer | Q72849361 | ||
| Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma | Q73303283 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thyroid carcinoma | Q18556131 |
| P304 | page(s) | 928-930 | |
| P577 | publication date | 1997-09-01 | |
| 1997-09-25 | |||
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Follow-up of patients with thyroid carcinoma | |
| Follow-up of Patients with Thyroid Carcinoma | |||
| P478 | volume | 337 |
| Q36196615 | A Quantitative Evaluation of Hepatic Uptake on I-131 Whole-Body Scintigraphy for Postablative Therapy of Thyroid Carcinoma |
| Q38253900 | Accuracy of positron emission tomography and positron emission tomography-CT in the detection of differentiated thyroid cancer recurrence with negative (131) I whole-body scan results: A meta-analysis |
| Q38224994 | Differentiated thyroid cancer-personalized therapies to prevent overtreatment. |
| Q73138058 | Effects of low-iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma |
| Q37894309 | Molecular nuclear therapies for thyroid carcinoma |
| Q36106044 | Pre-ablative diagnostic whole-body scan following total thyroidectomy for well-differentiated thyroid cancer: is it necessary? |
| Q37913996 | Radioiodine for remnant ablation and therapy of metastatic disease |
| Q47266547 | Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy |
| Q33647039 | Randomized trials on radioactive iodine ablation of thyroid remnants for thyroid carcinoma--a critique |
| Q77221760 | Staging in thyroid carcinoma |
| Q24548764 | The emerging role of pituitary tumor transforming gene in tumorigenesis |
| Q34435753 | The use of recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer |
| Q82810268 | Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma |
Search more.